Learn / BBIO
NASDAQ: BBIO
BridgeBio Pharma (BBIO) stock, explained like you're 5
BridgeBio Pharma trades on the Nasdaq under the ticker BBIO. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 12.8 billion dollars.
- Ticker
- BBIO
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Large cap, about 12.8 billion dollars
Is BridgeBio Pharma a small, medium or large cap company?
Yes. BridgeBio Pharma is a large cap stock. Its market cap, which is the total value of all its shares, is about 12.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How BridgeBio Pharma makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves BBIO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- BBIO Stock Surges 17% Pre Market Today What’s Fueling The Rally? (Stocktwits)
- 32 new hires get awards tied to 57,853 shares, but vesting depends on continued employment. (Stock Titan)
- BridgeBio Pharma (BBIO) Stock Looks Reasonable As Fresh Acoramidis Data Lands (Yahoo Finance)
- BridgeBio Pharma, Inc. Actuals & Estimates (BIVA:BBIO) (TradingView)
- BridgeBio Pharma, Inc. Stock (BBIO *) Quote Mexican S.E. (marketscreener.com)
Follow BBIO in your daily brief
Each trading day at 5 PM ET we post what happened to BridgeBio Pharma and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow BBIO
Questions about BridgeBio Pharma stock
What does BridgeBio Pharma do?
BridgeBio Pharma trades on the Nasdaq under the ticker BBIO. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 12.8 billion dollars.
What is the ticker symbol for BridgeBio Pharma?
BridgeBio Pharma trades under the ticker BBIO on the Nasdaq.
What is BridgeBio Pharma's market cap?
BridgeBio Pharma is a large cap stock with a market cap of about 12.8 billion dollars.
How does BridgeBio Pharma make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves BBIO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow BBIO stock every day?
Add BBIO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.